Results 91 to 100 of about 1,849,805 (333)

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Solutions Of The System Of Maximum Difference Equations

open access: yesMANAS: Journal of Engineering, 2014
The behaviour of the solutions of the following system of difference equations is examined.
Dağıstan Şimşek, Ahmet Doğan
doaj  

On a multidimensional close-to-cyclic system of difference equations

open access: yesMiskolc Mathematical Notes
This paper investigates the solvability and dynamic properties of the following multidimensional close-to-cyclic system of nonlinear difference equations yn+1 (i)=aiyn (i+1) (y n−k (i+1))pi+1+b i (yn−k+1 (i))pi;n∈ℕ0,yn (i+k)=yn (i),pi+k=pi,ai+k=ai,bi+
Yacine Halim   +2 more
doaj   +1 more source

On a system of difference equations of third order solved in closed form

open access: yesJournal of Innovative Applied Mathematics and Computational Sciences, 2021
In this work, we show that the system of difference equations xn+1=(ayn-2xn-1yn+bxn-1yn-2+cyn-2+d)/(yn-2xn-1yn), yn+1=(axn-2yn-1xn+byn-1xn-2+cxn-2+d)/(xn-2yn-1xn), where n belongs to the set of positive integer numbers, x-2, x-1, x0, y-2, y-1 and y0 are ...
Youssouf AKROUR   +2 more
doaj  

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

open access: yesMolecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris   +10 more
wiley   +1 more source

Solutions of the System of Maximum Difference Equations

open access: yesMANAS: Journal of Engineering, 2016
The behaviour and periodicity of the solutions of the following system of difference equations is ...
D. Şimşek, M. Eröz, B. Öğul
doaj  

On a System of Two High-Order Nonlinear Difference Equations

open access: yesAdvances in Mathematical Physics, 2014
This paper is concerned with dynamics of the solution to the system of two high-order nonlinear difference equations xn+1=xn-k/(q+∏i=0kyn-i), yn+1=yn-k/(p+∏i=0kxn-i), k∈N+, n=0,1,…, where p,q∈(0,∞), x-i∈(0,∞), y-i∈(0,∞) and i=0,1,…,k.
Qianhong Zhang, Wenzhuan Zhang
doaj   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy